Clinical trial data cloud market to reach $7.59 billion by 2030

By AI, Created 5:08 PM UTC, May 18, 2026, /AGP/ – The clinical trial data cloud market is projected to grow from $3.82 billion in 2025 to $7.59 billion by 2030 as drug developers, researchers and healthcare providers move more trial data into secure cloud systems. North America led the market in 2025, while Asia-Pacific is expected to grow fastest as clinical trial activity expands.

Why it matters: - Clinical trial data cloud platforms are becoming a core tool for handling larger, more complex trial datasets in real time. - The market’s growth points to wider adoption of digital infrastructure in drug development, data management and regulatory compliance. - Faster data access can improve collaboration across trial sites and speed decision-making in clinical research.

What happened: - The clinical trial data cloud market is projected to increase from $3.82 billion in 2025 to $4.37 billion in 2026. - The market is forecast to reach $7.59 billion by 2030. - The report projects a 14.5% CAGR from 2025 to 2026 and a 14.8% CAGR from 2026 to 2030. - The Business Research Company published the analysis on May 14, 2026.

The details: - Clinical trial data cloud platforms are secure cloud-based systems that store, manage and analyze clinical trial data as it is generated. - These platforms give researchers and healthcare organizations access to large volumes of patient and trial information. - The systems are designed to support data accuracy, regulatory compliance and collaboration across multiple research sites. - The report cites increasing digitization of clinical trials as a major growth driver. - Wider use of electronic data capture systems is also fueling adoption. - Multi-site trial collaboration is creating more demand for centralized data tools. - Stronger focus on patient data integrity is adding pressure for secure, auditable systems. - Broader cloud infrastructure in healthcare is supporting market expansion. - Demand for AI-powered clinical analytics is expected to accelerate growth through 2030. - Greater integration of genomics and biomarker data is another forecast driver. - Real-time patient monitoring is becoming a larger part of trial operations. - Growth in hybrid and public cloud solutions is expected to continue. - Regulatory and compliance automation is emerging as a key trend. - The report also flags expanding use of hybrid cloud models, patient recruitment and engagement technologies, safety management platforms, managed services and technical support. - In December 2024, the Association of the British Pharmaceutical Industry reported that industry-sponsored clinical trials in the UK rose from 411 in 2022 to 426 in 2023.

Between the lines: - The market forecast suggests clinical research is shifting toward always-on, data-heavy operations that favor cloud-based workflows. - North America’s lead reflects early adoption of advanced digital tools in clinical research. - Asia-Pacific’s expected growth signals rising trial activity and healthcare infrastructure buildout in the region. - The emphasis on automation and real-time analytics suggests buyers want fewer manual processes and faster oversight, not just storage.

What’s next: - Market growth is expected to be shaped by continued clinical trial digitization and broader use of hybrid cloud architectures. - Vendors will likely compete on analytics, compliance automation and trial collaboration tools. - Download a free sample of the report. - View the full market report.